Full View

Early versus delayed non–vitamin k antagonist oral anticoagulant therapy after acute ischemic stroke in atrial fibrillation (TIMING): a registry-based randomized …

J Oldgren, S Åsberg, Z Hijazi, P Wester, M Bertilsson… - Circulation, 2022 - Am Heart Assoc
Background: There are no evidence-based recommendations on the optimal time point to
initiate non–vitamin K antagonist oral anticoagulants (NOACs) after acute ischemic stroke in …
被引用次数：73 相关文章

Early Versus Delayed Non-Vitamin K Antagonist Oral Anticoagulant Therapy After Acute Ischemic Stroke in Atrial Fibrillation (TIMING): A Registry-Based Randomized …

J Oldgren, S Åsberg, Z Hijazi, P Wester, M Bertilsson… - 2022 - pubmed.ncbi.nlm.nih.gov
Background There are no evidence-based recommendations on the optimal time point to
initiate non-vitamin K antagonist oral anticoagulants (NOACs) after acute ischemic stroke in …

Early Versus Delayed Non-Vitamin K Antagonist Oral Anticoagulant Therapy after Acute Ischemic Stroke in Atrial Fibrillation (TIMING): A Registry-Based Randomized …

J Oldgren, S Åsberg, Z Hijazi, P Wester, M Bertilsson… - Circulation, 2022 - lup.lub.lu.se
Background: There are no evidence-based recommendations on the optimal time point to
initiate non-vitamin K antagonist oral anticoagulants (NOACs) after acute ischemic stroke in …
[HTML] acponline.org

[HTML][HTML] Early Versus Delayed Non–Vitamin K Antagonist Oral Anticoagulant Therapy After Acute Ischemic Stroke in Atrial Fibrillation (TIMING): A Registry-Based …

J Oldgren, S Åsberg, Z Hijazi, P Wester… - …, 2022 - journalwise.acponline.org
Background: There are no evidence-based recommendations on the optimal time point to
initiate non–vitamin K antagonist oral anticoagulants (NOACs) after acute ischemic stroke in …

Early Versus Delayed Non-Vitamin K Antagonist Oral Anticoagulant Therapy After Acute Ischemic Stroke in Atrial Fibrillation (TIMING): A Registry-Based Randomized …

J Oldgren, S Åsberg, Z Hijazi, P Wester, M Bertilsson… - Circulation, 2022 - diva-portal.org
Background: There are no evidence-based recommendations on the optimal time point to
initiate non–vitamin K antagonist oral anticoagulants (NOACs) after acute ischemic stroke in …

Early Versus Delayed Non-Vitamin K Antagonist Oral Anticoagulant Therapy after Acute Ischemic Stroke in Atrial Fibrillation (TIMING): A Registry-Based Randomized …

J Oldgren, S Åsberg, Z Hijazi, P Wester… - …, 2022 - portal.research.lu.se
Background: There are no evidence-based recommendations on the optimal time point to
initiate non-vitamin K antagonist oral anticoagulants (NOACs) after acute ischemic stroke in …

Early Versus Delayed Non–Vitamin K Antagonist Oral Anticoagulant Therapy After Acute Ischemic Stroke in Atrial Fibrillation (TIMING): A Registry-Based Randomized …

J Oldgren, S Åsberg, Z Hijazi, P Wester, M Bertilsson… - Circulation, 2022 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> Background:</jats: title>< jats: p> There are no evidence-based
recommendations on the optimal time point to initiate non–vitamin K antagonist oral …
[HTML] nih.gov

[HTML][HTML] Early Versus Delayed Non–Vitamin K Antagonist Oral Anticoagulant Therapy After Acute Ischemic Stroke in Atrial Fibrillation (TIMING): A Registry-Based …

J Oldgren, S Åsberg, Z Hijazi, P Wester, M Bertilsson… - Circulation, 2022 - ncbi.nlm.nih.gov
Background: There are no evidence-based recommendations on the optimal time point to
initiate non–vitamin K antagonist oral anticoagulants (NOACs) after acute ischemic stroke in …

Early Versus Delayed Non–Vitamin K Antagonist Oral Anticoagulant Therapy After Acute Ischemic Stroke in Atrial Fibrillation (TIMING): A Registry-Based Randomized …

J Oldgren, S Åsberg, Z Hijazi, P Wester, M Bertilsson - Circulation, 2022 - Am Heart Assoc
BACKGROUND: There are no evidence-based recommendations on the optimal time point
to initiate non–vitamin K antagonist oral anticoagulants (NOACs) after acute ischemic stroke …

Early Versus Delayed Non–Vitamin K Antagonist Oral Anticoagulant Therapy After Acute Ischemic Stroke in Atrial Fibrillation (TIMING): A Registry-Based Randomized …

J Oldgren, S Åsberg, Z Hijazi, P Wester… - …, 2022 - ingentaconnect.com
Background: There are no evidence-based recommendations on the optimal time point to
initiate non–vitamin K antagonist oral anticoagulants (NOACs) after acute ischemic stroke in …